340B Strategy for 2026 — Finance, Compliance & Operations
Significant 340B Program changes are coming in 2026 — with direct implications for hospital margins, compliance exposure and operational strategy.
In this HFMA webinar, Todd Nova and James Junger break down the financial impact of rebate models and manufacturer restrictions, discuss contract pharmacy challenges and outline strategies for optimizing DSH eligibility.
This session explores:
- Financial impact of 340B changes — including rebate models, manufacturer restrictions, Maximum Fair Price rules and Inflation Reduction Act provisions
- Strategies to address manufacturer and contract pharmacy restrictions while protecting access to 340B savings
- Optimizing DSH eligibility to support compliance and maximize reimbursement amid Medicaid cuts
Access the recording to gain practical insights that can help protect 340B savings and strengthen your organization’s financial position.
